机构:
Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Sang, Meixiang
[2
]
Wang, Lifang
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Hosp 2, Dept Lab, Shijiazhuang 050000, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Wang, Lifang
[3
]
Ding, Chunyan
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Ding, Chunyan
[1
]
Zhou, Xinliang
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Zhou, Xinliang
[1
]
Wang, Bin
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Wang, Bin
[2
]
Wang, Ling
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Wang, Ling
[2
]
Lian, Yishui
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Lian, Yishui
[1
]
Shan, Baoen
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
Shan, Baoen
[1
,2
]
机构:
[1] Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Med Univ, Hosp 2, Dept Lab, Shijiazhuang 050000, Hebei, Peoples R China
To date, dozens of melanoma-associated antigens (MACE) have been identified. Based on the differences in tissue-specific gene expression and gene structure, the MACE family has been divided into two big subfamilies: MACE-I and MACE-II. MACE-I genes were identified as a group of highly attractive targets for cancer immunotherapy because of their wide expression in a variety of malignant tumors but silent in normal adult cells except germ-line cells lacking human leukocyte antigen (HLA) expression. However, little is known regarding the functions of MACE family members in cell activities. In this review, we briefly described the classification of MACE family members and their expression pattern in cancer. We also summarized the mechanism of MACE activation and the functions of MACE family members in cell cycle progression and apoptosis. We also discussed what is known of immunotherapy targeting MACE family. (C) 2010 Elsevier Ireland Ltd. All rights reserved.